J. B. Chemicals & Pharmaceuticals Limited
Simbol: JBCHEPHARM.NS
NSE
1743.85
INRTržna cena danes
53.2431
Razmerje P/E
8.4545
Razmerje PEG
270.64B
Kapaciteta MRK
- 0.01%
Donos DIV
J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM-NS) Finančni izkazi
Bilanca stanja
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 2928.6 | 566.5 | 6936.6 | ||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 2159.3 | 1.1 | 6649.7 | ||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 5771.7 | 6238.8 | 4186.7 | ||||||||||||||||||
balance-sheet.row.inventory | 0 | 4304.9 | 4099.6 | 3474.5 | ||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 2275.1 | 1843.6 | 928.2 | ||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 15280.3 | 12748.5 | 15526 | ||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 5764.2 | 5668.2 | 5696.6 | ||||||||||||||||||
balance-sheet.row.goodwill | 0 | 574.6 | 574.6 | 574.6 | ||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 13222.8 | 6713.9 | 321.1 | ||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 13797.4 | 7288.5 | 895.6 | ||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 137.8 | 127.2 | 129.1 | ||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 65.1 | 64.3 | 69.4 | ||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 493.9 | 177.2 | 64.4 | ||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 20258.4 | 13325.5 | 6855.1 | ||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.total-assets | 0 | 35538.7 | 26074 | 22381.2 | ||||||||||||||||||
balance-sheet.row.account-payables | 0 | 2386.4 | 2244.8 | 1869.2 | ||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 1739.1 | 339.4 | 398.5 | ||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 49.5 | 60.9 | 79 | ||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 3985.4 | 206.2 | 51.4 | ||||||||||||||||||
Deferred Revenue Non Current | 0 | 152.1 | 31.7 | 49.3 | ||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 236.5 | 88.2 | 99.4 | ||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 5190.7 | 850.7 | 794.1 | ||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 242.1 | 282.4 | 123.4 | ||||||||||||||||||
balance-sheet.row.total-liab | 0 | 10735.2 | 4687.9 | 4246.9 | ||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.common-stock | 0 | 154.8 | 154.6 | 154.6 | ||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 22757.1 | 18427.1 | 15847.9 | ||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 2698.8 | 2248.4 | 1583.6 | ||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -807.1 | 511.2 | 511.2 | ||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 24803.5 | 21341.2 | 18097.2 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 35538.7 | 26074 | 22381.2 | ||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 44.9 | 37.1 | ||||||||||||||||||
balance-sheet.row.total-equity | 0 | 24803.5 | 21386.1 | 18134.3 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||||||
Total Investments | 0 | 323.9 | 128.1 | 130.9 | ||||||||||||||||||
balance-sheet.row.total-debt | 0 | 5724.5 | 545.6 | 449.9 | ||||||||||||||||||
balance-sheet.row.net-debt | 0 | 4955.2 | -19.9 | 163 |
Izkaz denarnih tokov
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 5552.3 | 5049 | 5968.9 | ||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 1144.1 | 726.6 | 686.7 | ||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -1146.7 | -1685.9 | 0 | ||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 693.7 | 626.5 | 0 | ||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -299.2 | -3025.2 | -942.1 | ||||||||||||||||||
cash-flows.row.account-receivables | 0 | -417.5 | -2928.4 | -706 | ||||||||||||||||||
cash-flows.row.inventory | 0 | -205.2 | -625.1 | -700.9 | ||||||||||||||||||
cash-flows.row.account-payables | 0 | 323.5 | 528.3 | 464.8 | ||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 0 | 0 | ||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 311.9 | 10.3 | -2565.6 | ||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -7649.5 | -7067.9 | -477.7 | ||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 1998.6 | -7003.9 | -85 | ||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -7568.7 | -5084.7 | -5412.1 | ||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 5570.1 | 12088.6 | 3169.1 | ||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | -1968.4 | 7091.1 | 498.9 | ||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -9617.9 | 23.2 | -2306.8 | ||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -872.5 | -3.3 | -3.2 | ||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 84.8 | 0 | 0 | ||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 5684.8 | 0 | 0 | ||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -1275.9 | -1275.6 | -732.4 | ||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -55.8 | -105 | -138.6 | ||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 3565.4 | -1383.9 | -874.2 | ||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0.3 | 0 | 0.4 | ||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 203.9 | 340.7 | -32.8 | ||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 769.3 | 565.4 | 224.7 | ||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 565.4 | 224.7 | 257.5 | ||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 6256.1 | 1701.3 | 3147.8 | ||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -7649.5 | -7067.9 | -477.7 | ||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -1393.4 | -5366.5 | 2670.1 |
Vrstica izkaza poslovnega izida
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 31492.8 | 24242.4 | 20058.5 | ||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 3842.2 | 8633.7 | 7174.4 | ||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 27650.6 | 15608.7 | 12884.1 | ||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 99.4 | 8.4 | 76.2 | ||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 13997.4 | 10862.7 | 8009.7 | ||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 3842.2 | 19496.5 | 15184.1 | ||||||||||||||||||
income-statement-row.row.interest-income | 0 | 25.4 | 9.3 | 17.7 | ||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 360.5 | 47.9 | 69.4 | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -365.6 | 310.1 | 1073.4 | ||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 99.4 | 8.4 | 76.2 | ||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -365.6 | 310.1 | 1073.4 | ||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 360.5 | 47.9 | 69.4 | ||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 1144.1 | 726.6 | 686.7 | ||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.operating-income | 0 | 5917.9 | 4739 | 4895.4 | ||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 27650.6 | 5049 | 5968.9 | ||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 893.1 | 1188.6 | 1483.6 | ||||||||||||||||||
income-statement-row.row.net-income | 0 | 4098.3 | 3853.6 | 4479.6 |
Pogosto zastavljeno vprašanje
Kaj je J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.NS) skupna sredstva?
J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.NS) skupna sredstva so 35538700000.000.
Kakšen je letni prihodek podjetja?
Letni prihodki so N/A.
Kolikšna je stopnja dobička podjetja?
Dobiček podjetja je 0.890.
Kakšen je prosti denarni tok podjetja?
Prosti denarni tok je 14.157.
Kolikšna je neto stopnja dobička podjetja?
Čista stopnja dobička je 0.152.
Kolikšni so skupni prihodki podjetja?
Celotni prihodki so 0.855.
Kaj je J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.NS) čisti dobiček (čisti dobiček)?
Čisti dobiček (čisti prihodek) je 4098300000.000.
Kolikšen je skupni dolg podjetja?
Skupni dolg je 5724500000.000.
Kolikšni so stroški poslovanja?
Stroški poslovanja so 13997400000.000.
Kolikšno je število denarnih sredstev podjetja?
Denarna sredstva podjetja so 0.000.